GlassScriptPhysician profile
Peirong Yu
NPI 1184711855
$3,531.33
in general payments reported to CMS, 2019-2025
12 companies · $789 in 2025
The $789 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.15 · 2020: $15.80 · 2022: $266 · 2023: $1,469 · 2024: $921 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,082 · Travel and Lodging: $97.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,081.97 |
| Travel and Lodging | $97.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $822.63 | 2023-2025 | Matrixcombo, Na, Matrixmandible |
| Musculoskeletal Transplant Foundation INC. | $727.64 | 2023-2025 | |
| Integra Lifesciences Corporation | $445.84 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $418.10 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Baxter Healthcare | $284.47 | 2020-2025 | |
| Tela Bio, INC. | $170.29 | 2022 | |
| Stryker Corporation | $160.13 | 2024 | 1788 |
| Axogen | $142.45 | 2023 | Avance Nerve Graft |
| Checkpoint Surgical, INC | $102.08 | 2023 | Checkpoint Stimulators |
| Allergan, INC. | $95.75 | 2022 | |
| Kerecis Limited | $91.80 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ethicon US, LLC | $70.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peirong Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.